Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Depression is a disease that affects millions of people around the world, but its diagnosis and treatment remain challenging. However, recent research has yielded promising results, discovering new biomarkers of depression that may help diagnose the disease more quickly and precisely. In this article, we will look at these findings and their potential implications for patients suffering from depression.
Tryptophan deficit and depression
One of the new biomarkers of depression is the deficit of tryptophan, which is an amino acid necessary for the production of serotonin – a neurotransmitter known as the “happiness hormone”. Studies have shown that people suffering from depression often have lower levels of tryptophan in their bodies, which may contribute to mood disorders.
It is worth noting that tryptophan deficiency can be easily diagnosed with a simple blood test. This discovery opens new possibilities for faster diagnosis of depression and adaptation of therapy to the individual needs of the patient.
Antranilic acid – a new biomarker of depression
Another promising biomarker is anthranilic acid, which is a product of the metabolism of tryptophan in the body. Studies have shown that people suffering from depression have increased concentrations of anthranilic acid in their urine. This discovery may be crucial for earlier detection of the disease and monitoring the effectiveness of treatment.
Researchers are working to develop a simple urine test that will quickly and precisely determine a patient’s anthranilic acid level. This is another step towards improving the diagnosis and treatment of depression.
Ccf-mtdna as a new biomarker of depression
Another interesting discovery is the relationship between depression and ccf-mtDNA, i.e. mitochondrial DNA circulating in the blood of patients. Studies have shown that people suffering from depression have an increased amount of ccf-mtDNA, which may be related to the inflammatory process in the body.
This discovery opens new perspectives in research on depression and its mechanisms. It can also help identify patients who require more intensive treatment or health monitoring.
Your suggestions
As science advances in diagnosing depression using biomarkers, there are many opportunities for further research and discovery. If you have suggestions or ideas for additional potential biomarkers, be sure to share them with scientists and mental health professionals. Your ideas may contribute to even more effective diagnosis and treatment of depression.
Recommended articles
If you are interested in the topic of depression and biomarkers, we recommend reading the following articles:
“Depression: Symptoms, causes and treatment methods” – an article presenting basic information about depression and its treatment.
“New methods of depression therapy: Gene therapy and psychotherapy” – discussion of modern approaches to the treatment of depression, including gene therapy.
“The importance of a healthy lifestyle in the fight against depression” – an article analyzing the impact of physical activity, diet and lifestyle on the course of depression.
The discovery of new biomarkers for depression represents a significant step towards improving the diagnosis and treatment of this disease. Thanks to this, patients will be able to receive appropriate help earlier, which can significantly improve their quality of life.